World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
30176
World Ranking
10140
National Ranking
144

Núria Malats publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Núria Malats sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 461 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Núria Malats D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Núria Malats sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Núria Malats is affiliated with the Spanish National Cancer Research Centre in Spain. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The scientist's work spans various subfields including oncology, surgery, molecular biology, cancer research, and pulmonary and respiratory medicine. Their main research topics cover pancreatic and hepatic oncology research, cancer genomics and diagnostics, bladder and urothelial cancer treatments, epigenetics and DNA methylation, cancer immunotherapy and biomarkers, urinary and genital oncology studies, as well as pancreatitis pathology and treatment.

They have published numerous papers in leading scientific venues. Frequent publication venues include:

  • Pancreatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Gut
  • European Urology
  • Cancer Epidemiology Biomarkers & Prevention

Notable recent papers include:

  • An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer, 2021, Nature Communications
  • A faecal microbiota signature with high specificity for pancreatic cancer, 2022, Gut
  • Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study, 2022, Gastroenterology
  • A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study, 2020, PLoS Medicine
  • FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?, 2020, European Urology

Frequent co-authors include:

  • Francisco X. Real
  • Evangelina López de Maturana
  • Alfredo Carrato
  • Lola Alonso
  • José Perea

Best Publications

  • A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

    Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

  • Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

    Mónica Gumá;Ana Angulo;Carlos Vilches;Natalia Gómez-Lozano

  • NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

    Montserrat García-Closas;Núria Malats;Debra Silverman;Mustafa Dosemeci

  • Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

    Cristina M. Villanueva;Kenneth P. Cantor;Joan O. Grimalt;Nuria Malats

  • Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

    Richard D. Riley;Jill A. Hayden;Ewout W. Steyerberg;Karel G. M. Moons

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

    Jakob Hedegaard;Philippe Lamy;Iver Nordentoft;Ferran Algaba

  • EphB receptor activity suppresses colorectal cancer progression

    Eduard Batlle;Julinor Bacani;Harry Begthel;Suzanne Jonkeer

  • A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

    Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

  • Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

    F Graus;J Dalmou;R Reñé;M Tora

  • Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

    Silvia Hernández;Elena López-Knowles;Josep Lloreta;Manolis Kogevinas

  • P53 as a prognostic marker for bladder cancer: a meta-analysis and review

    Núria Malats;Aurelia Bustos;Cristiane M Nascimento;Francisco Fernandez

  • Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage

    Miquel Porta;Xavier Fabregat;Núria Malats;Luisa Guarner

  • Epidemiology of urinary bladder cancer: from tumor development to patient's death.

    Cristiane Murta-Nascimento;Bernd J. Schmitz-Dräger;Maurice P. Zeegers;Gunnar Steineck

  • Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

    Brian M. Wolpin;Cosmeri Rizzato;Peter Kraft;Charles Kooperberg

  • Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

    Cristina Balbás-Martínez;Ana Sagrera;Enrique Carrillo-de-Santa-Pau;Julie Earl

  • Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.

    Yves Allory;Willemien Beukers;Ana Sagrera;Marta Flández

  • A degradation-sensitive anionic trypsinogen ( PRSS2 ) variant protects against chronic pancreatitis

    Heiko Witt;Miklós Sahin-Tóth;Olfert Landt;Jian Min Chen

  • Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study

    Lee E Moore;Ruth M Pfeiffer;Cristina Poscablo;Francisco X Real

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Francisco X. Real
Francisco X. Real Pompeu Fabra University
Alfredo Carrato
Alfredo Carrato University of Alcalá
Debra T. Silverman
Debra T. Silverman National Institutes of Health
Manolis Kogevinas
Manolis Kogevinas Pompeu Fabra University
Nathaniel Rothman
Nathaniel Rothman National Institutes of Health
Montserrat Garcia-Closas
Montserrat Garcia-Closas National Institutes of Health
Stephen J. Chanock
Stephen J. Chanock National Institutes of Health
Graham G. Giles
Graham G. Giles University of Melbourne
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Mustafa Dosemeci
Mustafa Dosemeci National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine goes beyond traditional medical school. Today, a range of online degrees provide flexible alternatives to support various roles in healthcare. For those interested in preventative care and wellness, consider one of the best online nutrition programs, which can lead to careers in dietetics, public health, or education.

If you are passionate about healthcare administration and leadership, cahme accredited mha online programs offer a pathway to management roles in hospitals and health systems.

Registered nurses seeking career advancement can benefit from rn to bsn programs that do not require clinical hours. These programs help deepen skills, improve patient outcomes, and open doors to broader nursing opportunities.

Those aiming for the highest level of nursing practice may opt for the shortest post master's dnp program. Earning a Doctor of Nursing Practice can lead to advanced clinical or leadership roles in healthcare.

Online degrees can address different career goals, offering flexibility for working professionals and diverse entry points into the dynamic field of medicine and healthcare.

Best Scientists Citing Núria Malats

Trending Scientists

Recently Published Articles